Advertisement

Topics

Agile Therapeutics Resubmits New Drug Application for its Transdermal Contraceptive Patch, Twirla

01:06 EDT 27 Jun 2017 | Drugs.com

PRINCETON, N.J., June 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate,...

Original Article: Agile Therapeutics Resubmits New Drug Application for its Transdermal Contraceptive Patch, Twirla

NEXT ARTICLE

More From BioPortfolio on "Agile Therapeutics Resubmits New Drug Application for its Transdermal Contraceptive Patch, Twirla"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...